Selective blockade of spinal P2X3 and P2X2/3 receptors with a novel and selective antagonist, AF-742, reveals central endogenous purinergic regulation of bladder activity

Kaan T K Y1, Yip P K1, Grist J1, Gever J R2, Cefalu J S3, Nunn P A3, Ford A P D W4, Zhong Y3, McMahon S B1

Abstract Category

Pharmacology: Basic Science

Abstract 602
Non-Discussion Posters
Scientific Non Discussion Poster Session 31
1. Wolfson Centre for Age-Related Diseases, King's College London, 2. Institute for Neurodegenerative Diseases, University of California, San Francisco, 3. Roche Palo Alto, 4. Afferent Pharmaceuticals